ITOC is currently priced at $0.28. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.